Surgery Partners (NasdaqGS:SGRY) FY Conference Transcript

Summary of Surgery Partners FY Conference Call (March 10, 2026) Company Overview - Company: Surgery Partners (NasdaqGS:SGRY) - Industry: Healthcare, specifically focused on surgical facilities and outpatient care Key Points and Arguments Market Dynamics - The company operates as an independent surgical facility amidst large integrated nonprofit systems that are moving away from Medicare Advantage (MA) contracts, impacting patient access and revenue [1] - There is a noted growth of 18% in high acuity procedures, but this growth was primarily driven by Medicare patients, leading to lower net revenue despite increased case volume [2][3] - The company is experiencing pressure from the Affordable Care Act (ACA) exchange patients, which affects their commercial patient mix and overall revenue [3][9] Financial Performance - Total case volumes fell below expectations due to payer mix issues, yet the company exceeded the high end of revenue guidance, indicating strong performance in high acuity cases [8] - The company is actively working on cost reduction and efficiency improvements to address margin compression faced by physicians [5][10] Strategic Initiatives - The company is focused on optimizing its portfolio by potentially divesting from larger facilities that have higher debt loads and lower free cash flow conversion [24][25] - A share repurchase program of $200 million has been authorized, indicating confidence in future cash flows from portfolio optimization efforts [26][28] Guidance and Future Outlook - The company has adopted a conservative approach to guidance for 2026, excluding unannounced M&A, while maintaining a target of at least $200 million for capital deployment [12][15] - There is an expectation that some market pressures will take time to resolve, particularly regarding MA and commercial access [9][11] Policy and Regulatory Environment - The company supports site neutrality in healthcare payments, believing that their facilities can provide care at a lower cost compared to traditional acute care settings [30][31] - The expiration of enhanced ACA subsidies has had a localized impact on patient volumes, particularly in one market where exchange patients were significant [33][36] Cost Structure and Anesthesia Challenges - The relationship between labor costs, anesthesia costs, and shifts in government payer mix is complex, with anesthesiologists facing reimbursement challenges that affect coverage and costs for the company [38][40] - The company is exploring ways to manage anesthesia costs more effectively, given the significant disparity in reimbursement rates between Medicare and commercial payers [39][40] Additional Important Insights - The company emphasizes the importance of physician partnerships and the need for better coordination to capture commercial patients effectively [7] - There is a strong focus on maintaining high patient experience and outcomes, which are critical for attracting and retaining physician partners [6][10] - The company believes that even in a potential economic slowdown, their value proposition as a lower-cost provider positions them well in the market [18][20]